MAS825
MAS82590 (Arumakimig) is a bispecific IL-1β and IL-18 monoclonal antibody that reduces inflammasome-mediated inflammation. MAS825 combines the anti-IL-1β and anti-IL-18 monoclonal antibodies (mAbs) inhibition domains in a single bispecific high-affinity cytokine capture molecule[1].
Product Specifications
Product Name Alternative
Arumakimig
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
95.83
Molecular Weight
(144.353 kDa)
References & Citations
[1]Hakim AD, et al. Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function. Clin Exp Immunol. 2023 Oct 13;213 (3) :265-275.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
031502-APC 200 µL
ABL, phosphorylated (Y412) (p150, Proto-oncogene c-Abl, Abelson murine leukemia viral oncogene homolog 1, Tyrosine-protein kinase ABL1, JTK7, ABL, ABL1) (APC) discontinued
Sign In for Pricing
View Details 
MMB63566-01 0.5 g
(5-Chloro-1-methyl-1H-1,3-benzodiazol-2-yl) methanamine
Sign In for Pricing
View Details MMB63566-02 5 g
(5-Chloro-1-methyl-1H-1,3-benzodiazol-2-yl) methanamine
Sign In for Pricing
View Details